Metraipolis › archive › dc_5c16ea86d538

Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42203742
DOI
10.1093/oncolo/oyag209
License (as archived)
solo-consultazione
Archived
2026-10-31T23:58:38.982Z
SHA-256 of the archived text
02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0
Stable URL of this page
https://metraipolis.com/documento/dc_5c16ea86d538

How to cite

Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742 — Europe PMC (en), https://europepmc.org/article/MED/42203742 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c16ea86d538 (Metraipolis archive dc_5c16ea86d538, sha256 02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0)
BibTeX
@misc{dc5c16ea86d538,
  title = {Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42203742},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c16ea86d538; sha256 02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42203742. Agents can read the archived copy with the MCP tool read_document.